Faculty Contact Info

OFFICE:  835 S Wolcott

         4035 COMRB, E511 MSB

PH #:  (312) 355-0236

EMAIL:  dmehta@uic.edu


LAB PAGE​​​​​​​

POSTDOCTORAL 

POSITIONS CURRENTLY AVAILABLE.

Please send CVs and

contact references to dmehta@uic.edu.

GRADUATE STUDENT ROTATION CURRENTLY AVAILABLE.

To discuss rotation projects contact 

dmehta@uic.edu.

Dolly Mehta, PhD

PROFESSOR OF PHARMACOLOGY & INTERIM HEAD DEPARTMENT OF PHARMACOLOGY

B.S., Rohilkhand University, India; Biological (1980).

PhD, Vallabh Bhai Patel, India; Biochemistry (1989).

Postdoc, Indiana University , Indianapolis; Cell Physiology (1997).

Research Interests 

My lab investigates interactive signaling between non-phagocytic (i.e., endothelial cells) and phagocytic cells (i.e., monocytes/macrophages) in regulating tissue function. We seek to understand how stressors (such as ligands for G-protein coupled receptors or toll-like receptors) on these cell types trigger metabolic and epigenetic changes to alter tissue function under physiological setting versus pathological (i.e., cancer) settings.

 

Specific projects are:

 

1) Vascular injury and repair. We investigate cellular signaling in endothelial cells that triggers vascular injury and those that repair the damage to reinstate tissue functions. We seek to understand how stressors (such as ligands for G-protein coupled receptors or toll-like receptors) on endothelial cells alter calcium signaling and endothelial transcriptome under physiological setting versus pathological (i.e., cancer) settings. We employ RNA-Seq transcriptomes, next generation scRNAseq and DNA sequencings, proteomics, cellular imaging and biochemical, immunological approaches and transgene/gene knock-out disease models to determine critical nodes in endothelial cells that can potentially be therapeutically targeted for restoring vascular homeostasis.

 

2) Myeloid cell interaction with endothelium. Our lab also investigates how reparative myeloid cells such as alveolar macrophages can be generated during lung injury. In this context, we study how metabolism tune epigenetic landscape of tissue macrophages during injury and repair. We also focus on assessing how these newly programmed cells can impact vascular signaling. We then targets specific signaling pathways identified by her lab to seek if these pathways can promote lung homeostasis. 

 

3) Therapeutic Targets. We have also launched into determining small molecules and peptides as therapeutic targets for preventing tissue injury and lung cancer.

Selected Awards and Honors

1998-2001

2003-2009

2010-2014

2014-

Member NIH Respiratory Integrative Biology and Translational Research Study Section

Giles Filley Award for Excellency in Physiology, American Physiological Society

Member NIH NHLBI RIBT Study Section

Associate Editor, The American Journal of Physiology-Lung Cellular and Molecular Physiology

Selected Publications

Yazbeck P, Tauseef M, Kruse K, Amin MR, Sheikh R, Feske S, Komarova Y, Mehta D. STIM1 Phosphorylation at Y361 Recruits Orai1 to STIM1 Puncta and Induces Ca2+ Entry. Sci Rep. 2017 Feb 20;7:42758.


Rajput C, Tauseef M, Farazuddin M, Yazbeck P, Amin MR, Avin Br V, Sharma T, Mehta D. MicroRNA-150 Suppression of Angiopoetin-2 Generation and Signaling Is Crucial for Resolving Vascular Injury. Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):380-8.


Tauseef M, Farazuddin M, Sukriti S, Rajput C, Meyer JO, Ramasamy SK, Mehta D. Transient receptor potential channel 1 maintains adherens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability. FASEB J. 2016 Jan;30(1):102-10.


Rajput C, Kini V, Smith M, Yazbeck Y, Chavez A, Thennes T, Knezevic N, Mehta D. N-WASP plays a critical role in re-annealing VE-cadherin adherens junctions. J Biol Chem. 288:4241-50, 2013.


Tauseef M, Knezevic N, Chava KR, Smith M, Sukriti S,Gianaris N, Obukhov AG, Vogel SM, Schraufnagel DE, Dietrich A, Birnbaumer L, Malik AB, Mehta D. TLR4 Activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation. J Exp Med. 209:1953-68, 2012.


Chava KR, Tauseef M, Mehta D. Cyclic AMP response element binding (CREB) protein prevents endothelial  permeability increase through transcriptional controlling p190RhoGAP expression. Blood. 119:308-19, 2012.


Kini V, Chavez A, Mehta D. A new role for PTEN in regulating transient receptor potential canonical channel 6-mediated Ca2+ entry, endothelial permeability and angiogenesis. J Biol Chem. 285:33082-91, 2010.


Knezevic N, Tauseef M, Thennes T, Mehta D.The G protein beta gamma subunit mediates re-annealing of adherens junctions to reverse endothelial permeability increase by thrombin. J Exp Med. 206:2761-77, 2009.


Tauseef M, Kini V, Knezevic N, Saba J, Vogel S, Ramchandran R, Malik AB, Mehta D.  Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ Res.103:1164-72, 2008.


Nebojsa K, Roy A, Timblin B, Konstantoulaki M, Malik AB, Mehta D. Requirement for GDI-1 phosphorylation at  serine 96 in the mechanism of RhoA activation and increased endothelial permeability. Mol Cell Biol. 27:6323-33, 2007.


Holinstat M, Knezevic N, Broman M, Samarel A, Malik AB, Mehta D. Suppression of rho activity by focal adhesion kinase-induced activation of p190RhoGAP: Role in restoring endothelial barrier function. J Biol Chem. 281:2296-305, 2006.


Jho DH, Mehta D., Ahmmed G, Gao X-P, Tiruppathi C, Broman MT, Malik AB. Angiopoietin-1 apposes VEGF-induced increase in endothelial permeability by inhibiting calcium entry through TRPC channels. Circ Res. 96:1282-90, 2005.


Mehta D., Konstantoulaki M, Ahmmed GU, Malik AB. Sphingosine 1-phosphate-induced mobilization of intracellular Ca2+ mediates Rac activation and adherens junction assembly in endothelial cells. J Biol Chem. 280:17320-8, 2005.